<DOC>
	<DOCNO>NCT00688480</DOCNO>
	<brief_summary>Cardiovascular relate disease main cause death patient kidney disease , `` oxidative stress '' think major contributor promote thicken heart muscle stiffen artery . Allopurinol , drug use safely treatment gout many year , find dramatically reduce `` oxidative stress '' . It therefore hop also reduce thickened heart muscle stiffen artery . If , likely reduce appallingly high cardiac death rate group kidney disease patient .</brief_summary>
	<brief_title>Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy Endothelial Dysfunction Cardiovascular Patients With Renal Dysfunction ?</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>CKD stage 3 Echo LVH Known heart failure Patients already Allopurinol Patients gout Patients hepatic disease Contraindications MRI , include severe claustrophobia Current immunosuppressive therapy , chlorpropamide , theophylline , 6 mercaptopurine Malignancy life threaten disease Pregnancy lactate woman Patients unable provide write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>CKD</keyword>
	<keyword>LVH</keyword>
	<keyword>Echo LVH</keyword>
	<keyword>Chronic Stage 3</keyword>
</DOC>